All questions
Safety: Stelara (ustekinumab) in plaque psoriasis
8 questions · 3 sources
Safety questions that apply to every indication of Stelara are on Stelara (ustekinumab), all indications: Safety.
Side effects
Do patients develop antibodies to Stelara in plaque psoriasis (immunogenicity)?
Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Note: The 6 to 12.4% range pools the plaque psoriasis and psoriatic arthritis trials; the label gives no separate range for plaque psoriasis.
What are the most common side effects of Stelara for plaque psoriasis?
“The most common adverse reactions (≥3% and higher than that with placebo) in adults from plaque psoriasis clinical trials for STELARA 45 mg, STELARA 90 mg, or placebo were: nasopharyngitis (8%, 7%, 8%), upper respiratory tract infection (5%, 4%, 5%), headache (5%, 5%, 3%), and fatigue (3%, 3%, 2%), respectively. The safety profile in pediatric patients with plaque psoriasis was similar to that of adults with plaque psoriasis.” (opens the source at this quote in a new tab)
Which Stelara side effects were more common than placebo in psoriasis trials?
Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Note: Table 9 columns are placebo, STELARA 45 mg, and STELARA 90 mg; the header row places STELARA above the 45 mg and 90 mg columns.
Warnings
Does Stelara increase the risk of serious infections?
“Serious infections requiring hospitalization, or otherwise clinically significant
infections, reported in clinical trials included the following:
• Plaque Psoriasis: diverticulitis, cellulitis, pneumonia, appendicitis, cholecystitis,
sepsis, osteomyelitis, viral infections, gastroenteritis, and urinary tract infections.” (opens the source at this quote in a new tab)
Does Stelara increase the risk of cancer?
Do patients need a TB test before starting Stelara?
Safety evidence
How often did infections occur with Stelara in psoriasis trials?
Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
What are the long-term side effects of Stelara for psoriasis?
Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy